A chart in the Sept. 11, 2000, issue of BioWorld Financial Watch mistakenly said Graffinity Pharmaceutical Design GmbH raised DM50 million (US$21.2 million) in a second funding round. The company actually is seeking to raise that amount.

Editor's Note: The correction already was made in BioWorld Online.